Effects of Intensive Insulin Therapy Within One Week on Glycemic Control and β-Cell Function in Patients with T2DM
Open Access
- 25 October 2026
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (21) , 8297
Abstract
Objective: To evaluate the impact of intensive insulin therapy (IIT) within 1 week on glycemic control and β-cell function indices in patients with type 2 diabetes mellitus (T2DM). Methods: This retrospective study included 726 patients with T2DM who underwent continuous subcutaneous insulin infusion within 1 week. Patients were divided into three groups based on disease duration: short (≤1 year), medium (>1 and p < 0.01 for both). HOMA-β, 30 min insulinogenic index, 30 min disposition index, and insulin secretion sensitivity index-2 markedly improved from baseline [37.69 (41.03) VS. 32.40 (46.06), 3.16 (3.97) VS. 2.12 (3.51), 336.85 (397.05) VS. 188.93 (263.45), and 185.92 (122.89) VS. 120.81 (90.12), respectively] (p < 0.01 for all). Insulin sensitivity, measured by HOMA-IR and Matsuda index, significantly improved (p < 0.01 for both). Significantly greater improvements in glycemic control and β-cell function measures were observed in patients with a shorter diabetes duration. Age, duration of diabetes, BMI, HbA1c, duration of IIT, and time in range were significantly associated with improvements in β-cell function indices. Conclusions: IIT within 1 week was associated with improved glycemic control and β-cell function indices in T2DM patients, with the most pronounced benefits observed in those with a shorter disease duration.Keywords
This publication has 34 references indexed in Scilit:
- Clinical application guidelines for blood glucose monitoring in China (2022 edition)Diabetes/Metabolism Research and Reviews, 2022
- The pancreatic β-cell in ageing: Implications in age-related diabetesAgeing Research Reviews, 2022
- Annual decline in β‐cell function in patients with type 2 diabetes in ChinaDiabetes/Metabolism Research and Reviews, 2020
- Insulin requirement profiles and related factors of insulin pump therapy in patients with type 2 diabetesScience China Life Sciences, 2019
- Standards of medical care for type 2 diabetes in China 2019Diabetes/Metabolism Research and Reviews, 2019
- Chinese clinical guidelines for continuous glucose monitoring (2018 edition)Diabetes/Metabolism Research and Reviews, 2019
- Decreased β-Cell Function is Associated with Cardiovascular Autonomic Neuropathy in Chinese Patients Newly Diagnosed with Type 2 DiabetesNeuroscience Bulletin, 2018
- Reduced Insulin Production Relieves Endoplasmic Reticulum Stress and Induces β Cell ProliferationCell Metabolism, 2016
- Determinants of glucose tolerance in impaired glucose tolerance at baseline in the Actos Now for Prevention of Diabetes (ACT NOW) studyDiabetologia, 2009
- Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in manDiabetologia, 1985